A phase 2a trial of IMM-1-104 plus chemotherapy demonstrated efficacy and tolerability in first- and second-line pancreatic ...
A new resource from the National Comprehensive Cancer Network (NCCN) provides evidence-based guidance on assessing and ...
A new report shows that cancer cases are increasing in females in the United States and in younger adults. For the first time ...
Annual cancer statistics report identifies persistent racial and ethnic disparities and increases in certain cancers in women ...
Pancreatic Cancer Action Network Calls for Urgently Needed Research and Funding for Effective Early Detection Strategy and ...
Today the American Cancer Society called out the need for more progress on pancreatic cancer, citing it as the third-leading ...
Oncolytics Biotech® Inc. , a leading clinical-stage company specializing in immunotherapy for oncology, today announced that Germany's medical regulatory body, the Paul-Ehrlich-Institute (PEI), has ...
News Medical on MSN1d
New NCCN Patient Resource Shares Latest Understanding Of Genetic Testing To Guide Patient Decision MakingThe new NCCN Guidelines for Patients®: Genetic Testing for Hereditary Breast, Ovarian, Pancreatic, and Prostate Cancer is ...
Progress in the treatment of pancreatic cancer has been notably slow and modest in contrast to other cancers of the GI tract over the last 5 years. Pancreatic cancer still continues to be a ...
A recent study that focused on women under 55 years old found an increase in pancreatic cancer cases. Mercy Medical Center Dr ...
MEMORY LOSS. IN TONIGHT’S WOMAN’S DOCTOR, A PANCREATIC CANCER IS RISING AMONG YOUNGER WOMEN. A RECENT STUDY FOCUSED ON WOMEN UNDER 55 YEARS OLD. MERCY MEDICAL CENTER ROWAN MANDOLIN SAYS THE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback